P rimary spinal column tumors arising from the neural elements are relatively rare lesions representing approximately 5% of adult primary central nervous system tumors.
include lipomas, spinal nerve sheath myxomas, paragangliomas, sarcomas, and vascular tumors. 1 Spinal neurofibromas are found in up to 38% of patients with neurofibromatosis Type 1 (NF1), 9, 19, 26, 27 one of the most common autosomal dominant disorders, affecting 1 in 3500 individuals, with significant heterogeneity in its clinical manifestation. 30 Spinal neurofibromas reportedly cause symptoms in approximately 5% of these patients; however, this estimate is probably too low. 12, 27, 29 Familial spinal neurofibromatosis is an alternate form of neurofibromatosis that is categorized by multiple neurofibromas symmetrically affecting the entire axial spine. 5, 20, 28 Spinal schwannomas are relatively rare with an incidence of 0.3-0.4 cases per 100,000 persons per year, and patients with these tumors generally present in the 4th or 5th decades of life. 24 An estimated 90% of schwannomas are sporadic and solitary lesions, 4% arise in the setting of NF Type 2 (NF2), and another 5% occur in multiples but are unassociated with NF2. 4 Neurofibromatosis Type 2 has an estimated incidence of 1 case in 25,000-40,000 persons and has the hallmark imaging finding of bilateral vestibular schwannomas. 17 A newer diagnosis of schwannomatosis has been described and by definition includes the phenotypic hallmark of multiple schwannomas without the involvement of cranial nerve VIII. Its prevalence is unknown, but its reported incidence ranges from 1 case in 40,000-700,000 persons, with most authors suggesting an incidence similar to that of NF2. 17 Malignant PNSTs have a worse prognosis than neurofibromas and schwannomas with an incidence of 1 case in 10,000 persons, but they are more common in patients with NF1, where over half of these tumors are found. 25 Spinal nerve sheath tumors are rare entities, and published studies are limited to single-institution case series. 3, 6, 8, 11, 14, [22] [23] [24] Studies focusing purely on surgical complications are limited. Among the studies in which surgical complications are defined as events such as wound infections, CSF leaks, deep venous thrombosis (DVT), or pulmonary complications, those by Fernandes et al. 11 and Seppälä et al. 23 cite rates of around 10%, whereas Nanda et al. 18 cite rates up to 30%; however, this latter study includes recurrence as a type of complication. When examining neurological outcomes such as new or worsening motor and sensory deficits, rates range from 5% to 30%. 6, 14, 15, [22] [23] [24] The goal of the present study was to identify the rates of new or worsening neurological deficits and surgical complications associated with the resection of spinal nerve sheath tumors treated at our institution and the potential factors related to these outcomes.
Methods
The Committee on Human Research, our institutional review board, approved all research activities.
Data Collection
Two authors (N.M.B. and C.P.A.) identified patients through a search of our institutional neuropathology database and a separate review of current procedural terminology (CPT) codes. These databases included 25 years of patient records (1991-present); however, most identified patients had been treated over the past decade (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) . In total, 5 surgeons contributed cases to this series: N.M.B, D.C., P.V.M., P.R.W., and C.P.A. Pathology records were reviewed to include the following PNSTs: neurofibromas, schwannomas, and malignant PNSTs (MPNSTs). Medical records were reviewed to include patient age at surgery and patient sex, presence of NF1 or NF2 according to clinical criteria, presenting symptoms and their duration, tumor location, tumor size (defined by spinal levels spanned by the tumor and its maximum diameter [cm] on MRI when available), extent of resection (defined by postoperative MRI or operative report), use of spinal fusion and number of levels fused, time to last follow-up, follow-up imaging, date of recurrence, and fusion-related complications. With respect to schwannomatosis, since it represents a new diagnostic entity, it is unknown how many patients included in the present study actually had this diagnosis compared with a diagnosis of sporadic schwannomas. Tumor location was classified by the level of the involved nerve root (cervical, thoracic, or lumbosacral) and anatomical location was classified as intradural, extradural, dumbbell, or paraspinal (tumors originating beyond the neural foramen). Extent of resection was defined as gross total if there was no evidence of residual disease on postoperative MRI and as subtotal if residual tumor was present. The use of intraoperative neuromonitoring was recorded and categorized as somatosensory evoked potentials (SSEPs), motor evoked potentials (MEPs), electromyography (EMG), or evoked EMG. Fusion-related complications were identified through postoperative progress notes, outpatient clinic notes, and postoperative imaging studies including conventional radiographs and CT scans. Complications were classified as follows: new or worsening sensory symptoms (numbness, paresthesias, dysesthesias), new or worsening weakness, wound infection, CSF leak or pseudomeningocele, spinal deformity (defined as any new symptomatic deformity requiring surgical correction), or other.
Statistical analysis
Univariate analysis of continuous variables was performed using the Student t-test, and categorical variables were compared using the chi-square or Fisher's exact test. Statistical significance was defined as p < 0.05. All analyses were performed with SPSS version 22 (IBM Corp.).
results

Patient Demographics
A total of 221 tumors in 199 patients were identified. Mean patient age at the time of surgery was 45 years with a range of 1-88 years. Demographics are summarized in Table 1 . There was a slight male predominance with 123 tumors (56%) in men and 98 tumors (44%) in women. A clinical diagnosis of NF1 was present in 42 cases (19%), NF2 in 11 cases (5%), and absent in 168 cases (76%). The mean duration of symptoms was 16 months, with pain as the most common presenting symptom (76%), followed by weakness (36%) and sensory changes (34%). There were 163 schwannomas (74%), 53 neurofibromas (24%), and 5 MPNSTs (2%). Tumors were distributed as follows: 85 cervical (38%), 62 thoracic (28%), and 74 lumbosacral (33%).
Location was intradural in 130 cases (59%), extradural in 26 cases (12%), dumbbell in 52 cases (24%), and paraspinal in 13 cases (6%). The majority of lesions (75%) were treated with gross-total resection (GTR). The mean followup time was 32 months.
Surgical Complications
There were 70 complications among the 221 tumors for a rate of 32%. The demographics of patients with and without complications are reviewed in Table 2 . There was no significant difference in age, sex, or presenting symptoms among patients who developed complications. Neurofibromatosis Type 2 was more common among patients with complications (10% vs 2%, p = 0.039), while NF1 was not (19% vs 19%, p = 0.911). Cervical and lumbosacral tumors had higher rates of complications (36% and 38%, respectively) than thoracic lesions (18%, p = 0.021).
Complication rates among tumor locations were as fol- of 13), a difference that was statistically significant (p = 0.033). Tumor pathology was not associated with complication rates; however, neurofibromas were associated with a lower rate of GTR. Complications were more common in the subtotal resection (STR) group than in the GTR group (44% vs 28%), although the difference between the 2 groups was not significant (p = 0.022). Neither the number of vertebral levels spanned by the tumor (1.2 vs 1.2 levels) nor the maximum tumor diameter (3.3 vs 3.8 cm) was associated with complication rates.
Intraoperative neuromonitoring was used in 47 (67%) of the 70 cases with postoperative complications compared with 104 (69%) of 151 cases without complications (p = 0.797). Among the 46 patients with any new or worsening motor or sensory symptom, intraoperative neuromonitoring was used in 35 cases (76%), compared with 116 (66%) of 175 cases without new neurological symptoms (p = 0.204). Among the 34 patients with new or worsening sensory symptoms, intraoperative neuromonitoring was used in 27 cases (79%); among the 12 patients with new or worsening motor deficits, neuromonitoring was used in 8 cases (67%). It was not feasible, and is beyond the scope of this paper, to determine whether neuromonitoring prevented postoperative deficits when it was used, because of changes in technique. Microsurgical technique was used in all cases. Surgical adjuncts such as ultrasonic aspirator and laser were used as indicated with no documented impact on individual complications.
Among the 70 complications, the most common were 34 new or worsening sensory symptoms (15%). Other complications included new or worsening weakness in 12 cases (5%), CSF leak or pseudomeningocele in 10 cases (4%), wound infection (including superficial and deep) in 11 cases (5%), and spinal deformity requiring surgical intervention in 5 cases (2%). Among the 12 cases of new or worsening weakness, 6 were new deficits and 6 represented a worsening of prior symptoms. Six cases involved planned nerve root sacrifice with expected postoperative deficits. Ten of the 12 cases involved weakness in a nerve root distribution, and 6 of those resulted in only mild deficits without any reported physical impairment. Two patients developed worsening bilateral lower-extremity weakness after surgery. One case occurred in a patient with multiple schwannomas from T-12 to L-3 who had presented with lower-extremity weakness and underwent tumor debulking for spinal cord compression. The second case was a patient with a large cervical schwannoma and intramedullary hemorrhage who had presented with weakness and myelopathy and underwent debulking for alleviation of spinal cord compression. Among the 10 CSF leaks or pseudomeningoceles, 8 were symptomatic with 5 of those requiring surgical repair; 2 cases were asymptomatic but nonetheless required surgical repair. Less common complications included 2 spinal epidural hematomas requiring a return to the operating room, 1 nonoperative cranial subdural hematoma, 1 DVT, 1 case of urinary retention, and 1 recurrent laryngeal nerve injury. Complications are summarized in Table 3 .
Among the 221 tumors, only 5 cases were associated with new spinal deformity. Four of these cases occurred in pediatric patients with NF1 who underwent multilevel cervical laminectomies for resection of neurofibromas without associated fusion procedures. Kyphotic deformities developed in each case, requiring return to the operating room for spinal fusion. One patient who underwent a spinal fusion with initial tumor resection developed a new spinal deformity. He had initially presented with a giant extradural schwannoma with paraspinal extension causing vena cava compression. He underwent L3-4 laminectomies with an L-3 pedicle subtraction osteotomy and L2-S1 instrumented posterior spinal fusion with pelvic fixation, followed by L2-4 anterior spinal fusion with partial L-3 corpectomy and interbody cage placement. He presented 2 years later with worsening back pain and right lower-extremity weakness. Imaging revealed proximal junctional kyphosis at L1-2 with an associated disc herniation causing severe canal stenosis. He underwent L1-2 laminectomies with discectomy and extension of his posterior instrumented fusion to T-10. At the last follow-up 53 months from his initial surgery, the patient was doing well with normal neurological function.
tumor Pathology and Complications
Complications among the different tumor pathologies were compared (Table 4) . Among 53 neurofibromas, there were 18 complications (34%) compared with 50 complications among 163 schwannomas (31%) and 2 complications among 5 MPNSTs (40%), differences that were not significant (p = 0.834). The rate of new or worsening sensory symptoms (21%) and motor deficits (8%) was slightly higher among neurofibromas than schwannomas (13% and 5%, respectively) or MPNSTs (20% and 0%, respectively); however, these differences were not significant (p = 0.427 and 0.658, respectively). Cerebrospinal fluid leaks or pseudomeningoceles (6%) and wound infections (7%) were more common among schwannomas than neurofibromas (2% and 0%, respectively) or MPNSTs (0% and 0%, respectively); again, however, these differences were not significant (p = 0.408 and 0.128, respectively). There was a higher rate of spinal deformity in the neurofibroma group (8%) than in the schwannoma (0.1%) or MPNST (0%) groups, and this difference was significant (p = 0.012).
tumor location and Complications
Complications after surgery for tumors in the cervical, thoracic, and lumbosacral spine were compared (Table 5) . There were 85 cervical, 62 thoracic, and 74 lumbosacral lesions with no significant differences in age or sex. Neurofibromatosis Type 1 was present in 31 cases of cervical tumors (36%) compared with 6 thoracic (10%) and 5 lumbosacral (7%) cases, a significant difference (p < 0.001).
Cervical tumors were associated with lower rates of pain at presentation (64%) than the rates associated with thoracic (82%) and lumbosacral (85%) lesions (p = 0.006).
Complications were identified in 31 cervical (36%), 11 thoracic (18%), and 28 (38%) lumbosacral tumors, which was a significant difference (p = 0.021). There were no significant differences in sensory or motor deficits among tumor locations. Cerebrospinal fluid leaks or pseudomeningoceles (8%) and wound infections (8%) were more common among lumbosacral tumors than cervical (4% and 2%, respectively) and thoracic (2% and 5%, respectively) tumors; however, these differences were not significant (p = 0.164 and 0.250, respectively). Rates of deformity were higher among cervical lesions (6%) than those among thoracic and lumbosacral lesions (0 and 1%, respectively, p = 0.065).
Potential associations between surgical complications and intradural, dumbbell, extradural, and paraspinal locations were explored and are summarized in Table 6 . Dumbbell tumors were associated with the highest rate of complications (48%) compared with intradural (26%), extradural (31%), and paraspinal (23%) tumors, a difference that was significant (p = 0.033). There was no statistically significant difference when comparing the type of complication and tumor location, but new or worsening motor deficits were higher among dumbbell tumors (6 13) lesions. The rate of GTR was also notably lower for dumbbell tumors (60%) compared with intradural (79%), extradural (85%), and paraspinal (77%) tumors, a difference that was significant (p = 0.027). Cerebrospinal fluid leaks, pseudomeningoceles, and wound infections were only present among intradural and dumbbell tumors.
extent of resection and Complications
Rates of surgical complications were compared between patients who underwent GTR and those who underwent STR (Table 7) . There were 166 patients in the GTR group and 54 in the STR group, with those in the former having a slightly older age (46 vs 41 years, p = 0.031) and those in the latter having a higher rate of NF1 (46% vs 10%, p < 0.001). Rates of NF2 were similar between the groups. Among the subtotally resected tumors, there were a higher rate of cervical lesions and lower rates of thoracic and lumbosacral lesions compared with rates among the gross totally resection lesions. Tumors in the STR group were also more likely to be neurofibromas and possess a dumbbell morphology compared with the GTR group. Tumors in the STR group were larger with a maximum di- ameter of 4.4 cm compared with 3.3 cm in the GTR group; however, this difference was not statistically significant (p = 0.072).
There were 24 complications in the STR group (44%) compared with 46 (28%) in the GTR group (p = 0.022). Rates of new or worsening sensory symptoms were 15% in the GTR group and 17% in the STR group (p = 0.777). Rates of new or worsening weakness were similar in the STR and GTR groups (7% vs 5%, respectively). There were no significant differences in the rates of CSF leak or pseudomeningocele, wound infection, or postoperative spinal deformity between the 2 groups. It was not possible to determine retrospectively if the use of neuromonitoring influenced whether GTR or STR was accomplished; however, the rate of GTR among cases with neuromonitoring was 79% compared with 66% in those without (p = 0.022). This difference remained significant for different modalities including MEPs, SSEPs, and EMG.
Discussion
The goal of this study was to describe outcomes in spinal nerve sheath tumor surgery and identify factors associated with new or worsening postoperative neurological deficits and surgical complications. Among the 221 tumors included in this study, there were 70 complications for a rate of 32%. We included new or worsening neurological deficits (motor and sensory) as complications even in cases in which they were expected given the need for nerve root sacrifice. Overall, the rate of new or worsening sensory symptoms was 15%; the rate of new or worsening weakness was 5%. Kim et al. examined their experience in the management of spinal schwannomas more than 20 years ago and found that among 31 patients who had undergone nerve sacrifice, 7 (22%) developed partial loss of strength or sensation, though none was debilitating. 15 Preoperative EMG was performed in a subset of these patients and showed that denervation was associated with an increased risk of postoperative deficit. These authors concluded that spinal roots associated with spinal schwannomas were often nonfunctional and that the risk of disabling neurological injury after nerve sacrifice was small.
In subsequent studies, Seppälä and colleagues assessed both neurological outcomes and complications related to wound healing and infection. 24 Among 142 spinal schwannomas with follow-up, 10 (7%) were considered clinically worse postoperatively; however, the specific symptoms were not described. Nineteen of the 187 patients in the study suffered complications related to wound infection or dehiscence, bleeding, DVT, or the lungs. In a similar study of 32 spinal neurofibromas, Seppälä et al. reported 5 neurological deteriorations (16%). 23 Late complications included spinal deformity in 2 patients and severe dysesthesias in another 2 patients. Among the 15 patients with nerve sacrifice who were alive at the last follow-up, 6 (40%) had sensory deficits and 5 (33%) had motor deficits, all of which were mild. In a more contemporary series, Safavi-Abbasi et al. examined complications in a cohort in which neurophysiological monitoring was used in most cases. 22 Among 131 cases of schwannoma, 16 (12%) developed sensory deficits and 3 (2%) had motor weakness. An additional 14 (11%) had CSF leaks or pseudomeningoceles, 5 (4%) had wound infections, 4 (3%) had meningitis, and 1 (1%) had spinal deformity. In other recent studies, Fernandes et al. reported a complication rate of 10% that included CSF fistula, wound infection, DVT, and pulmonary complication. 11 Nanda et al. reported 18 complications in 61 patients for a rate of 30%, which included pseudomeningocele and CSF leak in 5 cases (8%), instability in 2 cases (3%), wound infection in 3 cases (5%), and 1 case each of DVT, pulmonary embolism, incomplete recurrent laryngeal nerve injury, trigeminal nerve injury, and pseudarthrosis.
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In the current study we describe neurological outcomes and surgical complications in a series of 221 tumors treated at a single center. There was no difference in age, sex, clinical presentation, symptom duration, or extent of resection among patients when comparing those with new or worsening neurological outcomes and surgical complications and those without such outcomes. There was a higher incidence of NF2 in patients with complications, and although this difference was statistically significant, it may be related to the small sample size. There was no difference in complications when comparing different tumor pathologies or sizes; however, spinal level was an important factor since complications were more common among cervical and lumbosacral tumors than among thoracic spine lesions. Not surprisingly, this difference appears to be driven by increased rates of CSF leak, pseudomeningocele, and motor deficits. Rates of new or worsening neurological deficits did not significantly differ by spinal level; however, as expected, rates were lower among thoracic tumors compared with those among cervical or lumbosacral lesions. We observed a higher complication rate among dumbbell tumors; these lesions had the highest rate of new or worsening motor deficits and rates of CSF leak or pseudomeningocele and a wound infection rate that was similar to that for intradural lesions, although none of these differences met statistical significance.
Among 221 tumors, only 5 were associated with new spinal deformity. Four of these were cervical neurofibromas in pediatric patients who had undergone multilevel laminectomies without spinal fusion at the initial surgery. It is therefore appropriate to consider spinal fusion in these patients given their risk. We reported outcomes for patients with spinal nerve sheath tumors who had undergone spinal fusion with tumor resection and found that fusions were most common among dumbbell and extradural tumors as well as tumors at the cervicothoracic junction. 21 Rates of new or worsening neurological deficit, CSF leak, pseudomeningocele, and infection were no different among patients who underwent fusions compared with those who did not.
The rate of GTR in this series was 75%, which on initial review may seem lower than expected; however, the rate was driven by a high number of cervical neurofibromas in patients with NF1. Among schwannomas, the rate of GTR was 83% compared with 51% among neurofibromas. Among 53 neurofibromas included in this analysis, 74% of cases involved patients with NF1, 74% were located in the cervical spine, and 79% were either intradural or dumbbell lesions. The high rate of cervical lesions is probably driven by the fact that these tumors are more likely to be symptomatic and treated compared with neurofibromas at other spinal levels. The lower rate of GTR can be explained by the fact that NF1 is not a curable entity and that the goal of surgery in these cases is decompression of the spinal cord and neural elements and not necessarily complete tumor resection.
With respect to the use of intraoperative neuromonitoring, there was no difference in complication rates when comparing cases with and without this adjunct. This finding does not imply that neuromonitoring is not a useful tool in the resection of these lesions, but rather that the likelihood of a postoperative deficit is probably more attributable to the invasive nature of the specific tumor rather than an inability to identify functional nerve roots. Additionally, even in cases with neuromonitoring, tumor resection may inevitably require nerve root sacrifice, thus explaining the similar rates of postoperative motor and sensory deficits. Our overall rates of new or worsening sensory symptoms (15%) and new or worsening weakness (5%) are consistent with other reports. Interestingly, we found higher rates of intraoperative neuromonitoring use among tumors treated with GTR than among tumors treated with STR. The retrospective nature of this study makes it difficult to determine if the use of neuromonitoring was directly responsible for the higher rates of GTR, and although these findings are intuitive, they warrant future study.
This study is limited by its retrospective design and limited follow-up. The mean time from surgery to the last clinic visit was 32 months; therefore, our rates of new or worsening neurological deficit may actually be overestimates since in some cases neurological function can improve over time. Although we identified a statistically significant increase in surgical complications among patients with NF2, the sample numbers are too small to make any definitive conclusions about the increased risk in these patients, and future studies should investigate this potential relationship. The rarity of these lesions makes prospective analysis challenging, but future studies may also focus on pre-and postoperative imaging features that can predict ease of resection or anticipate intraoperative challenges so that a particular technique can be avoided to prevent postoperative deficits.
Conclusions
Resection is a safe and effective treatment for spinal nerve sheath tumors. New or worsening neurological deficits or surgical complications were present in 32% of cases. The most common was new or worsening sensory symptoms (15%), followed by new or worsening weakness (5%), CSF leak or pseudomeningocele (5%), wound infection (5%), and spinal deformity (2%). Complications were more common in cervical and lumbosacral tumors but had no association with patient age, clinical presentation, symptom duration, tumor size, or tumor pathology. Intradural and dumbbell tumors were associated with higher rates of CSF leak, pseudomeningocele, and wound infection. Use of intraoperative neuromonitoring was associated with a higher rate of GTR; however, determining the true effect of neuromonitoring in minimizing postoperative neuro- 
